What top creators are saying about BenevolentAI(BAI.AS)
An AI-focused biotech company considered a pure-play investment in AI drug discovery.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about BenevolentAI in the last 30 days yet.
Top creators covering BenevolentAI (BAI.AS)
The 1 sources with the most insights about BenevolentAI on Kazuha.
Latest insights about BenevolentAI (BAI.AS)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Friday, August 1, 2025
A high-risk, pure-play investment in the emerging AI drug discovery sector, highlighted by its partnership with Novartis.
Friday, August 1, 2025
A high-risk, pure-play investment in the emerging AI drug discovery sector, highlighted by its partnership with Novartis.
Discussed alongside BenevolentAI (BAI.AS)
Other assets that creators frequently mention in the same content as BenevolentAI.
Frequently asked
Which podcasters and creators cover BenevolentAI (BAI.AS) the most?
The most active sources covering BenevolentAI (BAI.AS) on Kazuha are PodcastAI. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about BenevolentAI (BAI.AS) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about BenevolentAI (BAI.AS) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside BenevolentAI (BAI.AS)?
Creators covering BenevolentAI (BAI.AS) most frequently also discuss LLY, NVS, NVDA, GOOGL, AAPL. See the "Discussed alongside" section above for full asset pages.